Figure 2
The table is divided into four main sections: Customers, Product/Services, Processes and activities, and Participants, Information, Technologies. The Customers section lists medicine agencies such as EMA, FDA, pharmaceutical companies, and scientists. The Product/Services section includes specifications for a stem cell-based medicinal product, scientific papers and patents, and approval from regulatory, ethical, and marketing experts. The Processes and activities section details the steps taken by scientists, data scientists, regulatory experts, ethical experts, and marketing experts in producing and evaluating stem cell-based medical products. The Participants section lists scientists, regulatory experts, ethics experts, and data scientists. The Information section includes scientific knowledge about stem cells and stem-cell research, preliminary development plans, modified development plans, experimental results, and scientific papers and patents. Row 1: Customers, Product/Services.Work system snapshot of a KiP for developing a stem cell-based medicinal product. (Source. Authors' own work)